(VIANEWS) – Bank OZK (OZK), Air Lease Corporation (AL), U.S. Bancorp (USB) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Bank OZK (OZK)
22.5% sales growth and 12.72% return on equity
Bank OZK provides various retail and commercial banking services. The company accepts various deposit products, including non-interest bearing checking, interest bearing transaction, business sweep, savings, money market, individual retirement, and other accounts, as well as time deposits. It also offers real estate, consumer and business purpose, indirect recreational vehicle and marine, commercial and industrial, government guaranteed, agricultural, small business, homebuilder, and affordable housing loans; business aviation and subscription financing services; and mortgage and other lending products. The company also provides trust and wealth services, such as personal, custodial, investment management, and retirement accounts, as well as corporate trust services comprising trustee, paying and registered transfer agent, and other incidental services. In addition, it offers treasury management services comprising automated clearing house, wire transfer, transaction reporting, wholesale lockbox, remote deposit capture, automated credit line transfer, reconciliation, positive pay, and merchant and commercial card services, as well as zero balance and investment sweep accounts. Further, the company provides ATMs; telephone, online, and mobile banking services; debit and credit cards; safe deposit boxes; and other products and services, as well as processes merchant debit and credit card transactions. As of December 31, 2020, it operated approximately 250 offices in Arkansas, Georgia, Florida, North Carolina, Texas, South Carolina, California, New York, and Mississippi. The company was formerly known as Bank of the Ozarks and changed its name to Bank OZK in July 2018. Bank OZK was founded in 1903 and is headquartered in Little Rock, Arkansas.
Earnings Per Share
As for profitability, Bank OZK has a trailing twelve months EPS of $4.46.
PE Ratio
Bank OZK has a trailing twelve months price to earnings ratio of 8.91. Meaning, the purchaser of the share is investing $8.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.72%.
Previous days news about Bank OZK(OZK)
- According to Zacks on Wednesday, 12 July, "On that note, let us look at companies like Lindsay (LNN Quick QuoteLNN – Free Report) , Bank OZK (OZK Quick QuoteOZK – Free Report) ,The PNC Financial Services Group (PNC Quick QuotePNC – Free Report) and Worthington Industries (WOR Quick QuoteWOR – Free Report) that have lately hiked their dividend payouts."
2. Air Lease Corporation (AL)
21.3% sales growth and 7.64% return on equity
Air Lease Corporation, an aircraft leasing company, engages in the purchase and leasing of commercial jet transport aircraft to airlines worldwide. The company also sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies, and airlines. In addition, it provides fleet management services to investors and owners of aircraft portfolios. As of December 31, 2019, the company owned a fleet of 275 aircraft, including 203 narrowbody jet aircraft and 89 widebody jet aircraft. Air Lease Corporation was founded in 2010 and is headquartered in Los Angeles, California.
Earnings Per Share
As for profitability, Air Lease Corporation has a trailing twelve months EPS of $4.03.
PE Ratio
Air Lease Corporation has a trailing twelve months price to earnings ratio of 10.41. Meaning, the purchaser of the share is investing $10.41 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.64%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 23.2% and 37.8%, respectively.
Volume
Today’s last reported volume for Air Lease Corporation is 129828 which is 80.33% below its average volume of 660350.
3. U.S. Bancorp (USB)
15.7% sales growth and 11.39% return on equity
U.S. Bancorp, a financial services holding company, provides various financial services to individuals, businesses, institutional organizations, governmental entities and other financial institutions in the United States. It operates in Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support segments. The company offers depository services, including checking accounts, savings accounts, and time certificate contracts; lending services, such as traditional credit products; and credit card services, lease financing and import/export trade, asset-backed lending, agricultural finance, and other products. In addition, it provides ancillary services comprising capital markets, treasury management, and receivable lock-box collection services to corporate and governmental entity customers. Further, the company offers asset management and fiduciary services for individuals, estates, foundations, business corporations, and charitable organizations. Additionally, it provides investment and insurance products to its customers principally within its markets, as well as fund administration services to mutual and other funds. Furthermore, the company provides corporate and purchasing card, and corporate trust services. The company offers merchant processing, investment management, ATM processing, mortgage banking, insurance, and brokerage and leasing services. U.S. Bancorp was founded in 1863 and is headquartered in Minneapolis, Minnesota.
Earnings Per Share
As for profitability, U.S. Bancorp has a trailing twelve months EPS of $3.61.
PE Ratio
U.S. Bancorp has a trailing twelve months price to earnings ratio of 9.92. Meaning, the purchaser of the share is investing $9.92 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.39%.
Yearly Top and Bottom Value
U.S. Bancorp’s stock is valued at $35.82 at 01:22 EST, way under its 52-week high of $49.95 and way above its 52-week low of $27.27.
Moving Average
U.S. Bancorp’s value is way above its 50-day moving average of $31.57 and way below its 200-day moving average of $40.12.
Previous days news about U.S. Bancorp(USB)
- According to Zacks on Tuesday, 11 July, "Banking stocks like Truist Financial Corporation (TFC Quick QuoteTFC – Free Report) and U.S. Bancorp (USB Quick QuoteUSB – Free Report) are worth a look as these too have robust dividend yields."
- : U.S. bancorp stock rises after B of A upgrade to buy from neutral. According to MarketWatch on Tuesday, 11 July, "He cut his 2023 earning estimate for U.S. Bancorp to $4.35 from $4.65 a share and also reduced his 2024 profit estimate to $4.10 a share from $4.65 a share."
- According to MarketWatch on Thursday, 13 July, "It said its top picks are Comerica , KeyCorp , Wells Fargo and Bank of New York Mellon , as it maintained a negative catalyst watch on U.S. Bancorp and opened negative catalyst watches on Fifth Third and Northern Trust ."
4. Masimo Corporation (MASI)
10.3% sales growth and 8.12% return on equity
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. The company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. The company offers coronavirus-2019 response and telehealth solutions; connectivity devices; and nasal high flow ventilation and neuromodulation solutions. The company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, physician offices, long term care facilities, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. Incorporated in 1989, the company is headquartered in Irvine, California.
Earnings Per Share
As for profitability, Masimo Corporation has a trailing twelve months EPS of $2.2.
PE Ratio
Masimo Corporation has a trailing twelve months price to earnings ratio of 74.8. Meaning, the purchaser of the share is investing $74.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.12%.
Moving Average
Masimo Corporation’s value is below its 50-day moving average of $170.44 and above its 200-day moving average of $159.13.
Revenue Growth
Year-on-year quarterly revenue growth grew by 85.7%, now sitting on 2.3B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 29.6% and positive 25% for the next.
Yearly Top and Bottom Value
Masimo Corporation’s stock is valued at $164.55 at 01:22 EST, way under its 52-week high of $198.00 and way above its 52-week low of $108.89.
5. ICON plc (ICLR)
5.9% sales growth and 6.1% return on equity
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. The company's clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional solutions, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON has an agreement with Evergreen Therapeutics, Inc. to conduct Phase II clinical trial for COVID-19 drug candidate. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.
Earnings Per Share
As for profitability, ICON plc has a trailing twelve months EPS of $6.23.
PE Ratio
ICON plc has a trailing twelve months price to earnings ratio of 40.16. Meaning, the purchaser of the share is investing $40.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.1%.
